| Literature DB >> 34797004 |
Francesca Conte1, Oreste De Rosa1, Marissa Lynn Rescott1, Teresa Pia Arabia1, Paolo D'Onofrio2, Alessio Lustro1, Serena Malloggi3, Danila Molinaro1, Paola Spagnoli1, Fiorenza Giganti3, Giuseppe Barbato1, Gianluca Ficca1.
Abstract
Studies on sleep during the Covid-19 pandemic have mostly been conducted during the first wave of contagion (spring 2020). To follow up on two Italian studies addressing subjective sleep features during the second wave (autumn 2020), here we assess sleep during the third wave (spring 2021) in a sample of healthy adults from Campania (Southern Italy). Actigraphic data (on 2 nights) and the Pittsburgh Sleep Quality Index were collected from 82 participants (40 F, mean age: 32.5 ± 11.5 years) from 11 March to 18 April 2021, when Campania was classified as a "red zone", i.e. it was subjected to strict restrictions, only slightly looser than those characterizing the first national lockdown (spring 2020). Although objective sleep duration and architecture appeared in the normal range, the presence of disrupted sleep was indexed by a relevant degree of sleep fragmentation (number of awakenings ≥ 1 min: 12.7 ± 6.12; number of awakenings ≥ 5 min: 3.04 ± 1.52), paralleled by poor subjective sleep quality (Pittsburgh Sleep Quality Index global score: 5.77 ± 2.58). These data suggest that the relevant subjective sleep impairments reported during the first wave could have relied on subtle sleep disruptions that were undetected by the few objective sleep studies from the same period. Taken together with sleep data on previous phases of the pandemic, our findings show that the detrimental effects on sleep determined by the initial pandemic outbreak have not abated across the subsequent waves of contagion, and highlight the need for interventions addressing sleep health in global emergencies.Entities:
Keywords: Covid-19 pandemic; actigraphy; objective sleep quality; sleep schedules; subjective sleep quality
Mesh:
Year: 2021 PMID: 34797004 PMCID: PMC8646572 DOI: 10.1111/jsr.13519
Source DB: PubMed Journal: J Sleep Res ISSN: 0962-1105 Impact factor: 5.296
Scores at PSQI subscales
| PSQI subscales (m ± SD) | |
|---|---|
| Sleep quality | 1.24 ± 0.65 |
| Sleep latency | 1.17 ± 0.87 |
| Sleep duration | 0.65 ± 0.65 |
| Sleep efficiency | 0.73 ± 1.01 |
| Sleep disturbances | 1.16 ± 0.48 |
| Use of sleep medications | 0.04 ± 0.34 |
| Daytime dysfunction | 0.82 ± 1.16 |
Higher scores indicate worse sleep quality, longer sleep latency, shorter sleep duration, lower sleep efficiency, greater sleep disturbances, greater use of sleep medications, greater daytime dysfunction, respectively (Buysse et al., 1989).
Actigraphic data on sleep schedules and sleep fragmentation
| Sleep Schedules (m ± SD) | |
|---|---|
| Bedtime (hr:min) | 00:33 ± 1:36 |
| Wake time (hr:min) | 08:33 ± 1:22 |
| Rise time (hr:min) | 08:41 ± 1:19 |
| Sleep midpoint (hr:min) | 04:36 ± 1:21 |
TST, total sleep time.
FIGURE 1Objective sleep architecture parameters in our participants, in reference to values recommended by the National Sleep Foundation (NSF) for each parameter. Grey areas represent recommended ranges for sleep duration (Hirshkowitz et al., 2015), sleep efficiency (SE), sleep‐onset latency (SOL) and wake after sleep onset (WASO; Ohayon et al., 2016). Black lines indicate the average value for each parameter observed in our sample
Gender differences in PSQI global score and sub‐scores
| PSQI subscales | Gender | m ± SD | Mann–Whitney's |
| Effect size |
|---|---|---|---|---|---|
| Sleep quality | M | 1.19 ± 0.63 | 790 | 0.602 | 0.059 |
| F | 1.30 ± 0.68 | ||||
| Sleep latency | M | 1.14 ± 0.89 | 802 | 0.713 | 0.045 |
| F | 1.20 ± 0.85 | ||||
| Sleep duration | M | 0.66 ± 0.68 | 840 | 10.000 | 0.000 |
| F | 0.65 ± 0.62 | ||||
| Sleep efficiency | M | 0.57 ± 0.88 | 712 | 0.183 | 0.152 |
| F | 0.90 ± 1.10 | ||||
| Sleep disturbances | M | 1.21 ± 0.47 | 756 | 0.306 | 0.100 |
| F | 1.10 ± 0.49 | ||||
| Use of sleep medication | M | 0.00 ± 0.00 | 798 | 0.150 | 0.050 |
| F | 0.10 ± 0.49 | ||||
| Daytime dysfunction | M | 0.73 ± 0.73 | 831 | 0.927 | 0.013 |
| F | 0.92 ± 1.49 | ||||
| PSQI global score | M | 5.61 ± 2.54 | 814 | 0.812 | 0.031 |
| F | 5.92 ± 2.63 |
Higher scores indicate worse sleep quality, longer sleep latency, shorter sleep duration, lower sleep efficiency, greater sleep disturbances, greater use of sleep medications, and greater daytime dysfunction, respectively (Buysse et al., 1989).
PSQI, Pittsburgh Sleep Quality Index.
Gender differences in objective sleep measures
| Sleep schedules | Gender | m ± SD | Student's |
| Effect size | 95%CI− | 95%CI+ |
|---|---|---|---|---|---|---|---|
| Bedtime (hr:min) | M | 01:00 ± 1:45 | 2.76 |
| 0.728 | 0.15 | 1.37 |
| F | 00:04 ± 1:17 | ||||||
| Wake time (hr:min) | M | 08:38 ± 1:22 | 0.577 | 0.565 | 0.128 | −0.25 | 0.46 |
| F | 08:28 ± 1:22 | ||||||
| Rise time (hr:min) | M | 08:78 ± 1:21 | 0.596 | 0.553 | 0.132 | −0.24 | 0.45 |
| F | 08:60 ± 1:19 | ||||||
| Sleep midpoint (hr:min) | M | 04:53 ± 1:28 | 1.945 | 0.055 | 0.430 | −0.00 | 1.09 |
| F | 04:19 ± 1:10 |
Significant differences are in bold.
SE, sleep efficiency; SOL, sleep‐onset latency; SPT, sleep period time; TIB, time in bed; TST, total sleep time; WASO, wake after sleep onset.
Differences in sleep schedules between subjects who participated in the study before DST and those who participated afterwards
| Sleep schedules | Before/after DST | m ± SD | Student's |
| Effect size | 95%CI− | 95%CI+ |
|---|---|---|---|---|---|---|---|
| Bedtime (hr:min) | Before | 00:21 ± 1:35 | −2.03 |
| 0.400 | −1.38 | −0.00 |
| After | 01:11 ± 1:32 | ||||||
| Wake time (hr:min) | Before | 08:20 ± 1:20 | −2.67 |
| 0.699 | −1.22 | −0.16 |
| After | 09:16 ± 1:14 | ||||||
| Rise time (hr:min) | Before | 08:28 ± 1:17 | −2.73 |
| 0.714 | −1.24 | −018 |
| After | 09:23 ± 1:12 | ||||||
| Sleep midpoint (hr:min) | Before | 04:24 ± 1:19 | −2.55 |
| 0.669 | −1.19 | −0.14 |
| After | 05:15 ± 1:15 |
Significant differences are in bold.
DST, Daylight Saving Time.